Search clinical trials for: Antimalarial treatment

Total 64789 results

University of Oxford
Mahidol Oxford Tropical Medicine Research Unit

Completed

P.Vivax Treatment Trial (Lao Pv)

Plasmodium Vivax

Lao People's Democratic Republic
Shehnoor Azhar

Completed

Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT (PROTECT)

COVID 19

Pakistan
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
LCMC Health

Terminated

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease (RCT)

COVID-19

United States
Susanne Arnold

Terminated

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

COVID | Sars-CoV2

United States
University of Texas Southwestern Medical Center

Completed

Atovaquone for Treatment of COVID-19

COVID-19

United States
International Brain Research Foundation

Withdrawn

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Covid19 | SARS (Severe Acute Respiratory Syndrome)
Avanir Pharmaceuticals

Completed

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Alzheimer's Disease | Agitation

United States
University of Maryland, Baltimore
National Institute on Aging (NIA)

Completed

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT)

Aneurysm

United States
Avanir Pharmaceuticals

Completed

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis (PRIME)

Multiple Sclerosis | Central Neuropathic Pain

United States, Spain, Czechia, Poland, Argentina
National Institute of Allergy and Infectious Diseases...

Completed

Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

HIV Infections | Bacterial Infections | Pneumonia, Pneumocystis Carinii

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Completed

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

HIV Infections | Toxoplasmosis, Cerebral

United States
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Completed

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
Johns Hopkins University
University of Wisconsin, Madison; Frantz Viral Therapeutics, LLC

Completed

Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) (ART-AIN)

Precancerous Conditions | Human Papilloma Virus | Anal Dysplasia | HPV-Related Anal Intraepithelial Neoplasia | AIN2/3 | Artesunate | Alternative Treatment

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...
Jacobus Pharmaceutical; Glaxo Wellcome

Completed

A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
Tanta University

Completed

Efficacy of Faviprevir in COVID-19 Treatment

COVID

Egypt
National Institute of Allergy and Infectious Diseases...
Jacobus Pharmaceutical; Fujisawa Pharmaceutical Co

Completed

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

HIV Infections | Toxoplasmosis, Cerebral

United States
Programme National de Lutte contre le Paludisme...

Completed

Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites

MALARIA

Niger
Shin Poong Pharmaceutical Co. Ltd.
Medicines for Malaria Venture

Completed

COVID-19 Treatment in South Africa

COVID-19

South Africa
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

COVID 19 | Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Tourcoing Hospital
Eric SENNEVILLE M.D. Ph.D.

Completed

Tedizolid Prolonged Treatment for Prosthetic Joint Infections (TEDIZOAM)

Prosthetic Joint Infection

France
National Institute for Medical Research, Tanzania
National Malaria Control Program, Tanzania

Active, not recruiting

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania (IPTsc)

Malaria

Tanzania
National Institute for Medical Research, Tanzania
Universiteit Antwerpen

Unknown

Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania (InSMART-school)

Anemia | Malaria,Falciparum

Tanzania
Centre Chirurgical Marie Lannelongue

Terminated

Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 (DHYSCO)

COVID-19 | Respiratory Distress Syndrome, Adult

France
Centers for Disease Control and Prevention
Ministry of Health, Brazil; Evandro Chagas National Institute of Infectious...

Completed

Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil

Malaria, Vivax | P Vivax

Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira...
Marcus Vinícius Guimarães de Lacerda; Mayla Gabriela Silva Borba; Wuelton Marcelo... and other collaborators

Completed

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
Tanta University

Completed

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

COVID-19 | Coronavirus Infection

Egypt
Cadrock Pty. Ltd.
Centre for Digestive Diseases, Australia

Terminated

Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease (ACAC-CHD)

Coronary Heart Disease | Chlamydophila Pneumoniae Infections

Australia
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
Kamuzu University of Health Sciences
Centers for Disease Control and Prevention

Completed

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi (STOPMIP-MW)

Pregnancy | Malaria

Malawi
Inova Health Care Services
United States Department of Defense; U.S. Army Medical Research and Development... and other collaborators

Completed

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)

Carcinoma, Intraductal, Noninfiltrating | DCIS | Ductal Carcinoma In Situ

United States
University of Illinois at Chicago

Withdrawn

Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

Dysplastic Nevus Syndrome

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment (Qure)

Fatigue Syndrome, Chronic | Q Fever | Coxiella Infection

Netherlands
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

COVID-19

Korea, Republic of
University of Southern California
National Cancer Institute (NCI)

Terminated

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Bandim Health Project
Karolinska Institutet

Completed

Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A

Malaria

Guinea-Bissau
Oxford University Clinical Research Unit, Vietnam
National Hospital for Tropical Diseases, Hanoi, Vietnam; Ministry of Health... and other collaborators

Completed

The Vietnam Chloroquine Treatment on COVID-19 (VICO)

COVID-19 | SARS-CoV-2 Infection

Vietnam
Duke University

Terminated

Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection

SARS-CoV-2

United States
Universidad Nacional de Colombia
Sanofi Pasteur, a Sanofi Company

Completed

Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia) (UNAL MALARIA)

P. Falciparum Malaria

Colombia
Sidney Kimmel Comprehensive Cancer Center at Johns...
Frantz Viral Therapeutics

Completed

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

Cervical Intraepithelial Neoplasia Grade 2/3 | High-risk HPV (Any Strain)

United States
Rochester General Hospital

Terminated

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma

United States
Groupe Hospitalier Paris Saint Joseph

Withdrawn

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome (OUTCOV)

COVID
University of Maryland, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID); Michigan State... and other collaborators

Completed

Malawi International Center of Excellence in Malaria Research School-based Cohort

Anemia | Malaria | Malaria,Falciparum
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Liverpool School of Tropical Medicine
London School of Hygiene and Tropical Medicine; University of Bergen; Kamuzu... and other collaborators

Completed

Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya

Malaria in Pregnancy | Adherence, Treatment

Kenya

Search clinical trials for: Antimalarial treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations